XML 32 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
NOTES
12 Months Ended
Dec. 31, 2023
NOTES  
NOTES

NOTE 11 — NOTES

On August 21, 2017, the Company issued $42,500,000 in aggregate principal amount of 5.75% fixed-rate notes due September 15, 2022 (the “2022 Notes”). On September 8, 2017, the Company issued an additional $6,375,000 in aggregate principal amount of the 2022 Notes pursuant to a full exercise of the underwriters’ overallotment option. On January 13, 2021, the Company caused notices to be issued to the holders of its 2022 Notes regarding the Company’s exercise of its option to redeem all of the issued and outstanding 2022 Notes, pursuant to the Second Supplemental Indenture dated as of August 21, 2017, between the Company and U.S. Bank National Association, as trustee. The Company redeemed all $48,875,000 in aggregate principal amount of the 2022 Notes on February 12, 2021. The 2022 Notes were redeemed at 100% of their principal amount, plus the accrued and unpaid interest thereon through the redemption date. As a result of the redemption, the Company recognized a loss on debt extinguishment of $539,250 due to the write off of the remaining deferred financing costs on the 2022 Notes. This loss is included in the Consolidated Statement of Operations for the year ended December 31, 2021.

The following table summarizes the interest expense and deferred financing costs on the 2022 Notes for the year ended December 31, 2021:

For the year ended

    

December 31, 2021

Interest expense

$

320,063

Deferred financing costs

 

28,231

 

Administration fees

9,000

Total interest and financing expenses

$

357,294

Loss on debt extinguishment(1)

 

539,250

Weighted average interest rate(2)

5.7

%

Effective interest rate (including fee amortization)(2)

6.4

%

Average debt outstanding(3)

$

48,875,000

Cash paid for interest

$

453,966

(1)The loss on debt extinguishment is not included in interest expense or net investment income.
(2)Excludes the loss on debt extinguishment.
(3)For the year ended December 31, 2021, the average is calculated for the period January 1, 2021 through February 12, 2021; the repayment date of the 2022 Notes.

On January 14, 2021, the Company issued $100,000,000 in aggregate principal amount of 4.875% fixed-rate notes due 2026 (the “2026 Notes”). The 2026 Notes will mature on March 30, 2026, and may be redeemed in whole or in part at any time or from time to time at our option on or after December 31, 2025 at a redemption price equal to 100% of the outstanding principal, plus accrued and unpaid interest. Interest on the 2026 Notes is payable semi-annually beginning September 30, 2021.

The Company used the net proceeds from the 2026 Notes offering to fully redeem the 2022 Notes and repay a portion of the amount outstanding under the Credit Facility. As of December 31, 2023, the aggregate carrying amount of the 2026 Notes was $98,996,412.

Prior to their redemption on February 12, 2021, the 2022 Notes were listed on New York Stock Exchange under the trading symbol “SCA”. As of December 31, 2022, the fair value of the 2022 Notes was $49,168,250. The 2026 Notes are institutional, non-traded notes. The 2026 Notes are carried at cost. At the measurement date, the estimated fair value of the 2026 Notes as prepared for disclosure purposes was $93,041,000. See Note 6 to the Consolidated Financial Statements for further discussion regarding the fair value measurements and hierarchy.

In connection with the issuance and maintenance of the 2026 Notes, the Company incurred $2,327,835 of fees, which are being amortized over the term of the 2026 Notes, of which $1,003,588 remains to be amortized as of December 31, 2023. These financing costs are presented on the Consolidated Statement of Assets and Liabilities as a deduction from the debt liability.

The following is a summary of the 2026 Notes Payable, net of deferred financing costs:

    

December 31, 2023

December 31, 2022

2026 Notes payable

$

100,000,000

$

100,000,000

Deferred financing costs

 

(1,003,588)

 

(1,450,308)

2026 Notes payable, net of deferred financing costs

$

98,996,412

$

98,549,692

The following table summarizes the interest expense and deferred financing costs on the 2026 Notes for the years ended December 31, 2023, 2022, and 2021:

For the year ended

 

    

December 31, 2023

    

December 31, 2022

    

December 31, 2021

 

Interest expense

$

4,881,000

$

4,885,000

$

4,698,958

Deferred financing costs

 

446,720

 

446,719

 

435,809

Total interest and financing expenses

$

5,327,720

$

5,331,719

$

5,134,767

Weighted average interest rate

 

4.9

%

 

4.9

%

 

4.9

%(1)

Effective interest rate (including fee amortization)

 

5.3

%

 

5.3

%

 

5.3

%(1)

Average debt outstanding

$

100,000,000

$

100,000,000

$

100,000,000

(1)

Cash paid for interest

$

4,881,000

$

4,885,000

$

3,466,667

(1)Calculated for the period from January 14, 2021, the date of the 2026 Notes offering, through December 31, 2021.

The indenture and supplements thereto relating to the 2026 Notes contain certain covenants, including but not limited to (i) a requirement that the Company comply with the asset coverage requirements of the 1940 Act or any successor provisions, and (ii) a requirement to provide financial information to the holders of the notes and the trustee under the indenture if the Company should no longer be subject to the reporting requirements under the Exchange Act. As of December 31, 2023, the Company was in compliance with these covenants.